GMO Pepabo, Inc. provided consolidated earnings guidance for the year ending December 31, 2024. For the year, the company expects net sales of ¥10,963 million, operating profit of ¥700 million, profit attributable to owners of parent ¥421 million and basic earnings per share of ¥79.95.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,394 JPY | -0.71% | +0.14% | +19.25% |
Feb. 13 | GMO Pepabo, Inc. Provides Dividend Guidance for the Year Ending December 31, 2024 | CI |
Feb. 13 | GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.25% | 46.63M | |
+30.99% | 470B | |
+33.63% | 276B | |
+3.90% | 135B | |
+30.50% | 94.76B | |
+62.27% | 61.13B | |
+14.09% | 46.6B | |
+25.91% | 38.08B | |
-0.62% | 35.74B | |
+12.07% | 29.13B |
- Stock Market
- Equities
- 3633 Stock
- News GMO Pepabo, Inc.
- GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024